THERAMEX Revenue and Competitors

Belgravia, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • THERAMEX's estimated annual revenue is currently $113.4M per year.(i)
  • THERAMEX's estimated revenue per employee is $201,000

Employee Data

  • THERAMEX has 564 Employees.(i)
  • THERAMEX grew their employee count by 1% last year.

THERAMEX's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Pharmacovigilance OfficerReveal Email/Phone
3
Head ProcurementReveal Email/Phone
4
Head Supply Planning & LogisticsReveal Email/Phone
5
Head Global Demand PlanningReveal Email/Phone
6
Head ProcurementReveal Email/Phone
7
General CounselReveal Email/Phone
8
Head Pharmacovigilance and Medical InformationReveal Email/Phone
9
PV OfficerReveal Email/Phone
10
PV OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is THERAMEX?

We are Theramex // www.theramex.com info@theramex.com A new global women's healthcare company that provides innovative, effective and safe solutions that care for and support women at every stage of their life. Our aim is to become a lifetime partner for women and for the healthcare professionals who treat them. Theramex has been a recognised brand for many decades - but since the purchase of Teva Pharmaceuticals' (Teva) Women's health division in February 2018, Theramex has been re-born as a separate, privately-held company dedicated to Women's Health. Theramex currently operates in 50 countries, across 5 continents. Our team is made up of over 250 passionate and multi-disciplinary medical professionals, supported by a network of distributors. Our established product portfolio offers a wide range of clinically proven prescription products in 4 clinical areas: - Contraception - Fertility - Menopause - Osteoporosis We are actively looking to expand our product portfolio and geographical presence. We would love to hear about interesting partnership opportunities. We are actively recruiting in London as well as other geographies across the world - please see our Careers Page for further details, or get in touch with us.

keywords:N/A

N/A

Total Funding

564

Number of Employees

$113.4M

Revenue (est)

1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

THERAMEX News

2022-03-22 - CVC Fund VI agrees exit of Theramex – CVC

Global investment firms PAI Partners and Carlyle (NASDAQ: CG) today announce that they have agreed to acquire Theramex, the leading global...

2022-03-22 - Carlyle, PAI Agree to Buy CVC's Women's Health Business ...

and PAI Partners agreed to buy women's health business Theramex from private equity firm CVC Capital Partners. The consortium announced the...

2022-03-22 - Carlyle and PAI Partners consortium to acquire Theramex ...

Theramex was created following the carve-out of a portfolio of women's health pharma products in 2018, and has subsequently developed into one...

2019-03-17 - EMEA News In Brief (March 18, 2019)

... PR and digital communications agency Road has been appointed on a women's health brief by pharmaceutical company Theramex to work

2019-02-28 - Pfenex and Alvogen Expand Development and Commercialization

Subject to applicable regulatory approvals, PF708 will be commercialized in Europe and Switzerland by Theramex, a leading global specialty

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M66613%N/A
#2
$183.5M9042%N/A
#3
$374.4M11737%N/A
#4
$474M1254-2%N/A
#5
$507.3M13427%N/A